Literature DB >> 20387180

[Resistance to antibiotics and multiresistant pathogens].

Klaus Kerwat1, Martina Kerwat, Jürgen Graf, Hinnerk Wulf.   

Abstract

Resistance to antibiotics and the directly related proportion of multiresistant bacterial pathogens (MRP) is increasing continuously. This applies particularly for intensive care units. The most relevant MRP are methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended spectrum ss-lactamase formers (ESBL), multiresistant pseudomonades and Acinetobacter species. According to WHO the world is in danger of entering a so-called "post-antibiotic era", in which it is no longer possible to treat the causes of infectious diseases with antibiotics. The reasons for this development are considered to be the increased morbidity of patients as well as the too frequent, too long-enduring and often inappropriate usage of antimicrobial substances. But also the increasing number of invasive measures and interventions as well as the still existing inadequate maintenance of hygiene standards and the inadequate establishment of non-medicamentous measures (e.g. hand disinfection) for infection prophylaxis play a significant role. Georg Thieme Verlag Stuttgart. New York.

Entities:  

Mesh:

Year:  2010        PMID: 20387180     DOI: 10.1055/s-0030-1253091

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  2 in total

1.  Pharmacological screening of methanolic extract of Ixora species.

Authors:  Lachimanan Yoga Latha; Ibrahim Darah; Kassim Jain; Sreenivasan Sasidharan
Journal:  Asian Pac J Trop Biomed       Date:  2012-02

2.  Frequency of resistance to methicillin and other antimicrobial agents among Staphylococcus aureus strains isolated from pigs and their human handlers in Trinidad.

Authors:  Annika Gordon; Jennelle Marshall; Kris Ramdass; Alva Stewart-Johnson; Abiodun Adesiyun
Journal:  Infect Ecol Epidemiol       Date:  2014-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.